Vector-borne diseases such as Dengue, Malaria, and Chikungunya continue to impose a massive health burden across tropical and subtropical regions. Transmitted by mosquitoes, these infections frequently present with overlapping symptoms including high fever, chills, joint pain, and rashes, making accurate diagnosis extremely challenging through conventional methods. Misdiagnosis delays treatment and increases the risk of complications, severe illness, and outbreaks. With early and reliable detection being the cornerstone of effective management, there is an urgent need for advanced diagnostic solutions capable of simultaneously identifying these pathogens with speed and precision.
The Para-Q Multiplex Real-Time PCR Kit from Genes2Me is an innovative in vitro diagnostic assay designed for the qualitative detection of nucleic acids specific to Dengue virus, Malaria parasite, and Chikungunya virus in a single test. By combining advanced multiplex technology with robust quality controls, the kit enables timely diagnosis, effective patient management, and better outbreak preparedness.
Genes2Me is a CE Marked molecular diagnostics company trusted by clinical laboratories across global markets. The Para-Q Multiplex Real-Time PCR Kit meets European conformity standards for in vitro diagnostic devices, validated to international benchmarks for accuracy, reliability, and safety.
The Para-Q kit uses a multiplex real-time PCR format with multiple primer-probe sets, enabling simultaneous detection and differentiation of three pathogens in a single reaction. Each target is assigned a dedicated fluorescence channel:
An Internal Control in the Cy5 channel validates every step from extraction to amplification, ensuring result accuracy and minimising false negatives. A positive control template is included to confirm assay performance, and a no-template control ensures reagent integrity and eliminates contamination risks. Ready-to-use reagents and a straightforward protocol minimise hands-on time and reduce the potential for procedural errors.
Dengue, Malaria, and Chikungunya share overlapping clinical presentations that make differential diagnosis difficult without laboratory confirmation. Serological testing may lack sensitivity in early infection, and single-pathogen assays require multiple tests and additional time. Multiplex molecular detection of pathogen-specific nucleic acids provides the earliest confirmation of active infection, ahead of antibody seroconversion, and is critical for initiating appropriate treatment promptly. The four-channel detection design with built-in internal control ensures that every negative result reflects a true absence of target pathogens rather than a failed reaction.
Simultaneously detects and differentiates Dengue virus, Malaria parasite, and Chikungunya virus in a single reaction using dedicated fluorescence channels, saving time and resources compared to running individual assays.
The positive control validates assay performance in every run, while the no-template control confirms reagent integrity and eliminates contamination risks.
Reliable identification of low pathogen loads, enabling confident diagnosis during early or subclinical infection.
The Cy5-channel internal control validates every step from nucleic acid extraction to amplification, ensuring result reliability and minimising false negatives.
Results available significantly faster than conventional serological or microscopy-based methods, enabling clinicians to initiate timely and targeted patient management.
Validated on RapiCycler 96, Bio-Rad CFX96, QuantStudio 5, and LightCycler 480, supporting seamless integration into existing laboratory workflows.
| Commercial Name | Old Cat No. | New Cat No. | Pack Size |
|---|---|---|---|
| Para-Q Multiplex Real-Time PCR Kit | G2M706121 | 50 Tests |
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
© 2025 Genes2me. All rights reserved.
